Cargando…
The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas
Mitogen-activated protein kinases (MAPKs) include ERK, p38, and JNK MAPK subfamilies, which are crucial regulators of cellular physiology, cell pathology, and many diseases including cancers. For the MAPK signaling system in pituitary adenomas (PAs), the activation of ERK signaling is generally thou...
Autores principales: | Lu, Miaolong, Wang, Ya, Zhan, Xianquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558377/ https://www.ncbi.nlm.nih.gov/pubmed/31231308 http://dx.doi.org/10.3389/fendo.2019.00330 |
Ejemplares similares
-
Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas
por: Long, Ying, et al.
Publicado: (2019) -
Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues
por: Qian, Shehua, et al.
Publicado: (2019) -
Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients
por: Cheng, Tingting, et al.
Publicado: (2019) -
Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas
por: Li, Na, et al.
Publicado: (2019) -
Editorial: Molecular Network Study of Pituitary Adenomas
por: Zhan, Xianquan, et al.
Publicado: (2020)